Latest Research And Development News

Page 63 of 81
TruScreen Group Limited reported a 19% revenue decline in FY2025 due to delayed rollouts in key emerging markets but anticipates a strong rebound with FY2026 sales forecast to exceed NZ$2.8 million.
Ada Torres
Ada Torres
26 May 2025
EBR Systems has announced a fully underwritten A$55.9 million capital raise alongside a Security Purchase Plan to fund the commercial rollout of its FDA-approved WiSE CRT System, targeting a US$3.6 billion market opportunity in cardiac resynchronization therapy.
Ada Torres
Ada Torres
22 May 2025
AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.
Ada Torres
Ada Torres
22 May 2025
AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.
Victor Sage
Victor Sage
22 May 2025
Nufarm Limited reported a 3% revenue increase to $1.81 billion for the half-year ended March 2025, driven by Crop Protection volume growth. However, net profit after tax fell 39% amid fish oil pricing pressures and higher operating costs, prompting the board to withhold an interim dividend.
Ada Torres
Ada Torres
21 May 2025
Light & Wonder unveiled ambitious growth targets and strategic plans at its 2025 Investor Day, spotlighting strong financial momentum and the integration of Grover Charitable Gaming. The company aims for $1.4 billion consolidated AEBITDA in 2025, underpinned by robust R&D and market leadership.
Victor Sage
Victor Sage
21 May 2025
Ardea Resources has received a $1.2 million R&D tax incentive rebate from the Australian Government, reinforcing its innovative work at the Kalgoorlie Nickel Project and strengthening its financial position.
Maxwell Dee
Maxwell Dee
21 May 2025
Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.
Ada Torres
Ada Torres
20 May 2025
TechnologyOne Limited has reported a robust first half for FY25, with annual recurring revenue exceeding $500 million well ahead of schedule and profit before tax climbing 33%. The company’s SaaS+ platform and strategic acquisition of CourseLoop are driving growth and positioning it for ambitious long-term targets.
Sophie Babbage
Sophie Babbage
20 May 2025
TechnologyOne has reported record half-year results, boosting full-year profit growth guidance to 13%–17%, driven by its pioneering SaaS+ ERP platform and strategic expansion.
Sophie Babbage
Sophie Babbage
20 May 2025
Etherstack plc has reported its highest ever half-year cash receipts, surpassing US$7 million in the first half of FY2025, signaling strong momentum and a promising revenue outlook for the year.
Sophie Babbage
Sophie Babbage
16 May 2025
HITIQ Limited has announced a non-renounceable entitlement offer to raise up to $2.92 million, supported by partial underwriting from GBA Capital and accompanied by new options issuance. The capital raise aims to fund expansion, product development, and operational growth.
Sophie Babbage
Sophie Babbage
15 May 2025